Home > PJ (current issue) > The Society / News Centre | Search
Society produces clinical governance framework for prescribing
The Royal Pharmaceutical Society has published a clinical governance framework to help ensure that patient safety is an integral part of pharmacist prescribing. The framework is for use by pharmacist prescribers and organisations throughout Britain that commission or participate in pharmacist prescribing.
This framework has been developed from the viewpoints of both the individual pharmacist prescriber and the organisation. For the individual it provides suggested indicators of good practice for pharmacist prescribing and examples of good clinical governance practice relating to prescribing. On the organisational side it looks at the organisational components of clinical governance and what might need to be put in place within an organisation to support clinical governance of pharmacist prescribing. The organisations it is aimed at include primary care organisations, NHS trusts, the private and voluntary health care sector and all organisations that employ pharmacist prescribers providing care to both NHS and non-NHS patients.
The Society’s head of quality improvement, Heidi Wright, said: “The quality and safety of health care provided to patients is a priority for all health care professionals. Pharmacists have a variety of opportunities to provide a broad range of services to patients and improve access and usage to medicines. Prescribing is a developing and expanding role for pharmacists and it is important that it is conducted in a safe and effective manner.
“This clinical governance framework should be used in conjunction with the competency framework for pharmacist supplementary prescribers developed by the National Prescribing Centre. Many of the recommendations in the Society’s clinical governance framework need to be implemented as part of the wider organisational work on managing prescribing and medicines management.”
The guidance is available from the clinical governance section of the Society’s website. Further information is available from Heidi Wright (tel 020 7572 2602; e-mail firstname.lastname@example.org).
Back to Top
©The Pharmaceutical Journal
Citation: The Pharmaceutical Journal